Reference health

Path-Breaking Directions of Nanotechnology-Based Chemotherapy and Molecular Cancer Therapy

https://doi.org/10.2139/ssrn.2581723
CiteStamped reference-health badge
1 of 66 checkable references need attention · checked 2026-08-03

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

8 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

does not resolve to a known work10.1080/09537325.2014.88
The 65 checked references that resolve
resolves10.1109/nssmic.2013.6829717
The 3-D elemental imaging method research based on photoneutron analysis
resolves10.1142/9789812819949_0008
Experimental Results and Discussions
resolves10.4324/9781315796888-8
Summary, Lessons Learned and Concluding Thoughts
resolves10.7554/elife.18566.096
Appendix 1—table 21.
resolves10.1109/9780470547038.ch2
Current References
resolves10.1007/s11192-012-0903-6
Capturing new developments in an emerging technology: an updated search strategy for identifying nanotechnology research outputs
resolves10.1016/j.bioelechem.2009.06.016
Carbon nanotubes based electrochemical biosensor for detection of formaldehyde released from a cancer cell line treated with formaldehyde-releasing anticancer prodrugs
resolves10.1016/j.addr.2013.11.009
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
resolves10.1016/j.proghi.2010.11.001
Quantum Dots Brighten Biological Imaging
resolves10.1002/wnan.114
Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases
resolves10.1080/09537325.2012.705117
Evolutionary trajectories of the nanotechnology research across worldwide economic players
resolves10.1504/ijhtm.2012.050616
Converging genetics, genomics and nanotechnologies for groundbreaking pathways in biomedicine and nanomedicine
resolves10.1504/ijbhr.2012.051406
Evolutionary growth of knowledge in path-breaking targeted therapies for lung cancer: radical innovations and structure of the new technological paradigm
resolves10.1016/j.techsoc.2012.06.002
Driving forces of technological change in medicine: Radical innovations induced by side effects and their impact on society and healthcare
resolves10.1007/s10549-013-2683-y
The effect of country wealth on incidence of breast cancer
resolves10.1016/j.hlpt.2013.09.007
Path-breaking target therapies for lung cancer and a far-sighted health policy to support clinical and cost effectiveness
resolves10.1080/09537325.2014.882501
Converging scientific fields and new technological paradigms as main drivers of the division of scientific labour in drug discovery process: the effects on strategic management of the R&D corporate change
resolves10.1016/j.msec.2013.09.019
Nanotechnology meets 3D in vitro models: Tissue engineered tumors and cancer therapies
resolves10.1016/j.jconrel.2012.01.043
PLGA-based nanoparticles: An overview of biomedical applications
resolves10.2174/157341311795542444
Carbon Nanotubes as an Advanced Drug and Gene Delivery Nanosystem
resolves10.1016/j.biotechadv.2013.10.013
Nanotechnology-based intelligent drug design for cancer metastasis treatment
resolves10.1016/j.technovation.2011.10.007
Which model of technology transfer for nanotechnology? A comparison with biotech and microelectronics
resolves10.1211/jpp.62.02.0016
3-Acetyl-11-keto-β-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity
resolves10.1002/wnan.85
<i>In vivo</i> near‐infrared fluorescence imaging of cancer with nanoparticle‐based probes
resolves10.1002/wnan.82
Nanodevices in diagnostics
resolves10.1016/j.techfore.2012.09.010
Four dimensional Science and Technology planning: A new approach based on bibliometrics and technology roadmapping
resolves10.1007/s10961-009-9149-8
Nanoscience and technology publications and patents: a review of social science studies and search strategies
resolves10.1016/j.biotechadv.2013.08.003
Highlights of recent developments and trends in cancer nanotechnology research—View from NCI Alliance for Nanotechnology in Cancer
resolves10.1016/j.bpg.2011.10.014
Chemoprevention in gastroenterology
resolves10.1016/j.technovation.2009.10.002
An empirical analysis of nanotechnology research domains
resolves10.1016/j.cll.2011.10.001
Role of Nanodiagnostics in Personalized Cancer Therapy
resolves10.1007/s11192-007-0308-0
Nanotechnology as a field of science: Its delineation in terms of journals and patents
resolves10.1007/s11517-010-0677-z
Micro and nanotechnology for biological and biomedical applications
resolves10.1007/s11192-007-0302-6
Language trends in nanoscience and technology: The case of Chinese-language publications
resolves10.1016/j.biomaterials.2011.06.024
A review of NIR dyes in cancer targeting and imaging
resolves10.1016/j.techfore.2012.10.016
On the assignment of biopharmaceutical patents
resolves10.1016/j.technovation.2012.01.003
The future of nanotechnologies
resolves10.1016/j.respol.2007.02.005
Data search strategy for science and technology emergence: A scalable and evolutionary query for nanotechnology tracking
resolves10.1016/j.techfore.2013.02.013
Observing regional divergence of Chinese nanotechnology centers
resolves10.1016/j.techfore.2011.03.013
Bibliometry and nanotechnology: A meta-analysis
resolves10.1016/j.techfore.2009.06.006
Trajectory patterns of technology fusion: Trend analysis and taxonomical grouping in nanobiotechnology
resolves10.3109/07388551.2010.487184
Quantum dots synthesis and biological applications as imaging and drug delivery systems
resolves10.1016/j.tibtech.2013.10.004
The potential legacy of cancer nanotechnology: cellular selection
resolves10.1021/nn300365m
Tailor-Made Quantum Dot and Iron Oxide Based Contrast Agents for <i>in Vitro</i> and <i>in Vivo</i> Tumor Imaging
resolves10.1007/s11192-009-0041-y
Diversity and network coherence as indicators of interdisciplinarity: case studies in bionanoscience
resolves10.1016/j.techfore.2011.06.004
Forecasting Innovation Pathways (FIP) for new and emerging science and technologies
resolves10.1016/j.chembiol.2010.11.013
Biocompatible Quantum Dots for Biological Applications
resolves10.1093/nar/gnh140
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle
resolves10.1016/j.drup.2011.01.003
Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
resolves10.1057/abm.2009.15
From lab to market? Strategies and issues in the commercialization of nanotechnology in China
resolves10.1038/468627a
Follow the money
resolves10.1039/c2jm16903g
CpG-DNA loaded multifunctional MnO nanoshuttles for TLR9-specific cellular cargo delivery, selective immune-activation and MRI
resolves10.1007/978-1-61779-319-6_16
Engineered Multifunctional Nanotools for Biological Applications
resolves10.1007/978-1-61779-052-2_23
Navigating the Patent Landscapes for Nanotechnology: English Gardens or Tangled Grounds?
resolves10.1016/j.jbi.2010.03.001
NanoParticle Ontology for cancer nanotechnology research
resolves10.1016/j.techfore.2012.05.002
The pharmaceutical technology landscape: A new form of technology roadmapping
resolves10.1016/j.technovation.2011.12.001
Influence of partner diversity on collaborative public R&amp;D project outcomes: A study of application and commercialization of nanotechnologies in the Netherlands
resolves10.1007/s10637-012-9891-x
EGFR and HER2 inhibition in pancreatic cancer
resolves10.1007/s11192-012-0856-9
Interdisciplinarity of nano research fields: a keyword mining approach
resolves10.1016/j.jconrel.2011.11.031
Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers
resolves10.1016/j.ctrv.2012.02.003
Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment
resolves10.1016/j.biomaterials.2011.01.038
The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery
resolves10.1007/s11051-008-9360-9
Nanotechnology publications and citations by leading countries and blocs
resolves10.1016/j.ipm.2006.03.016
Delineating complex scientific fields by an hybrid lexical-citation method: An application to nanosciences
resolves10.1002/asi.21440
Hybrid citation-word representations in science mapping: Portolan charts of research fields?
The 8 references without a DOI — listed, not checked
no DOI — not checkedref10
no DOI — not checkedref19
no DOI — not checkedref23
no DOI — not checkedref36
no DOI — not checkedBiocompatible Quantum Dots for Biological Applications
no DOI — not checkedWorking Paper Cnr-Ceris
no DOI — not checkedref73
no DOI — not checkedref74
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-08-03 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.2581723"><img src="https://citestamp.com/citestamped/10.2139/ssrn.2581723/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.2581723/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.2581723)